Northstar Asset Management Inc. Has $10.57 Million Stake in Stryker Corporation $SYK

Northstar Asset Management Inc. cut its stake in shares of Stryker Corporation (NYSE:SYK) by 6.1% in the 2nd quarter, Holdings Channel.com reports. The fund owned 33,581 shares of the medical technology company’s stock after selling 2,179 shares during the period. Stryker comprises about 3.1% of Northstar Asset Management Inc.’s holdings, making the stock its 9th largest position. Northstar Asset Management Inc.’s holdings in Stryker were worth $10,573,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of SYK. State Street Corp lifted its stake in shares of Stryker by 2.1% in the fourth quarter. State Street Corp now owns 15,254,407 shares of the medical technology company’s stock worth $5,374,731,000 after buying an additional 311,507 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Stryker by 0.6% during the second quarter. Wellington Management Group LLP now owns 8,167,185 shares of the medical technology company’s stock valued at $2,571,357,000 after acquiring an additional 45,478 shares in the last quarter. Geode Capital Management LLC raised its holdings in Stryker by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company’s stock worth $2,636,238,000 after acquiring an additional 69,851 shares during the last quarter. Norges Bank purchased a new position in Stryker in the 4th quarter worth approximately $1,822,272,000. Finally, Bank of America Corp DE bought a new position in Stryker in the 2nd quarter valued at approximately $1,404,284,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Stryker Stock Up 2.9%

SYK stock opened at $331.32 on Friday. The company has a market cap of $127.08 billion, a price-to-earnings ratio of 34.33, a P/E/G ratio of 2.05 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The business’s 50-day moving average is $329.10 and its two-hundred day moving average is $331.47. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.86.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. During the same period in the previous year, the company posted $3.13 EPS. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, analysts forecast that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio is currently 36.48%.

Insiders Place Their Bets

In other news, Director Ronda E. Stryker sold 300,000 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the sale, the director directly owned 2,301,375 shares in the company, valued at $773,031,862.50. This represents a 11.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Debra King sold 826 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the transaction, the insider directly owned 6,210 shares in the company, valued at approximately $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 351,267 shares of company stock worth $118,197,701. Company insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

SYK has been the topic of several recent analyst reports. Leerink Partners dropped their price objective on Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. BMO Capital Markets initiated coverage on shares of Stryker in a report on Wednesday, July 8th. They set an “outperform” rating and a $369.00 price objective for the company. Citigroup restated a “buy” rating on shares of Stryker in a research report on Thursday, August 13th. Finally, Sanford C. Bernstein set a $410.00 target price on shares of Stryker in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $386.28.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.